Next Article in Journal
Numerical Encodings of Amino Acids in Multivariate Gaussian Modeling of Protein Multiple Sequence Alignments
Next Article in Special Issue
The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy
Previous Article in Journal
Ethnomedicinal, Phytochemical and Pharmacological Investigations of Perilla frutescens (L.) Britt.
Previous Article in Special Issue
Insulin Mimetic Properties of Extracts Prepared from Bellis perennis
Open AccessArticle

Preparation and Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing the Bioavailability

1
College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China [email protected] (H.-X.C.)
2
Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Zhengzhou 450046, China
3
Forestry and biotechnology College, Zhejiang Agriculture and Forestry University, Lin’an 311300, China
4
Jiyang College of Zhejiang Agriculture and Forestry University, Zhu’ji 311800, China
5
Zhejiang Chinese Medical University, Zhejiang, Hangzhou, 310053, China
*
Author to whom correspondence should be addressed.
Academic Editor: Béla Juhász
Molecules 2019, 24(1), 103; https://doi.org/10.3390/molecules24010103
Received: 26 November 2018 / Revised: 23 December 2018 / Accepted: 24 December 2018 / Published: 28 December 2018
(This article belongs to the Special Issue Bioactive Compounds for Metabolic Syndrome and Type 2 Diabetes-II)
Berberine has many pharmacological effects, such as antidiabetic, antimicrobial, anti-inflammatory, and antioxidant, but the question remains on how its low oral bioavailability has greatly limited its clinical application. As a safer hypoglycemic agent, we must evaluate the bioavailability of berberine organic acid salts (BOAs) to ensure that the bioavailability of berberine is not negatively affected. It has been proven that the bioavailability of BOAs is higher than that of BH (berberine hydrochloride); especially BF (berberine fumarate) and BS (berberine succinate), which are improved by 1.278-fold and 1.313-fold, respectively. After 1 h of oral administration, berberine mainly acted on the stomach of mice, it also influenced the liver, kidney, lungs, and intestines after 4 h. The accumulation of BF in the lung is more evident than BH. Our analysis shows that these results are closely related to the regulation of organic acids and berberine in the intestinal tract, they also indicate the influence of intestinal flora on berberine metabolism. View Full-Text
Keywords: berberine organic acid salts; type 2 diabetes; pharmacokinetics; in-vivo imaging; intestinal flora berberine organic acid salts; type 2 diabetes; pharmacokinetics; in-vivo imaging; intestinal flora
Show Figures

Figure 1

MDPI and ACS Style

Cui, H.-X.; Hu, Y.-N.; Li, J.-W.; Yuan, K.; Guo, Y. Preparation and Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing the Bioavailability. Molecules 2019, 24, 103.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop